Use of Ketamine in Elderly Patients with Treatment-Resistant Depression

Curr Psychiatry Rep. 2017 Nov 15;19(12):107. doi: 10.1007/s11920-017-0855-x.

Abstract

Purpose of review: The purpose of this paper is to provide a review of the use of ketamine as an antidepressant for treatment-resistant depression (TRD) in the geriatric population. Available treatment options for late-life treatment-resistant depression are limited and include electroconvulsive therapy and transcranial magnetic stimulation as well as possible pharmacologic augmentation. Ketamine has been shown to be a promising treatment in TRD; however, data regarding the use of ketamine in the elderly includes only five case reports.

Recent findings: We discuss the use of ketamine for late-life TRD and present two cases where ketamine led to a significant and sustained improvement in depressive symptoms. Ketamine is a promising treatment for geriatric patients with TRD. Further studies in the elderly will provide valuable insights into the use of ketamine for a population much in need of safe and effective treatments for TRD.

Keywords: Antidepressants; Depression; Elderly; Geriatric; Ketamine; Resistant.

Publication types

  • Review

MeSH terms

  • Aged
  • Antidepressive Agents / therapeutic use*
  • Depressive Disorder, Treatment-Resistant / drug therapy*
  • Depressive Disorder, Treatment-Resistant / psychology
  • Humans
  • Ketamine / therapeutic use*
  • Treatment Outcome

Substances

  • Antidepressive Agents
  • Ketamine